Prof Alastair Forbes

Photo

Personal Profile

Name: Alastair Forbes Email: a.forbes@ucl.ac.uk
Title: Prof Tel: 08451 555000
Department: Div of Medicine Fax: 020 7380 9699
Position: Address: Maple House, UCH, 235 Euston Road, London, NW1 2BU
Research Domain: Neuroscience, Personalised Medicine Web Page:  

Profile

Research Description


Research Activities

Anaemia in Surgery

Inflammatory bowel disease

Role of hepatic inflammation in vascular dysfunction

clinical nutrition

intestinal tissue engineering

Education Description

UCL Collaborators

Prof John Porter; Prof Christopher Denton; Dr Raj Mookerjee; Prof Rajiv Jalan; Mr Toby Richards; Prof Surjit Kaila Singh Srai

External Collaborators

Publications

    2014

    • Czuber-Dochan W, Norton C, Berliner S, Bredin F, Darvell M, Forbes A, Gay M, Nathan I, Ream E, Terry H (2014). PWE-120 What Do Healthcare Professionals Know About Fatigue In Patients With Ibd And How Do They Manage It?. Gut, 63 Suppl 1, A177 - A178. doi:10.1136/gutjnl-2014-307263.380
    • Czuber-Dochan W, Norton C, Berliner S, Bredin F, Darvell M, Forbes A, Gay M, Nathan I, Ream E, Terry H, Bassett P (2014). PWE-121 Development And Psychometric Testing Of An Inflammatory Bowel Disease Fatigue (ibd-f) Patient Self-assessment Scale.. Gut, 63 Suppl 1, A178 - . doi:10.1136/gutjnl-2014-307263.381
    • Forbes A (2014). Crohn's disease: rehabilitation after resection.. Dig Dis, 32(4), 395 - 398. doi:10.1159/000358144
    • Forbes A (2014). The importance of guidelines for the dietary management of Crohn's disease in adults.. J Hum Nutr Diet, 27(3), 205 - 206. doi:10.1111/jhn.12196
    • Wong S, Derry F, Jamous A, Hirani SP, Forbes A (2014). Is undernutrition risk associated with an adverse clinical outcome in spinal cord-injured patients admitted to a spinal centre?. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 68(1), 125 - 130. doi:10.1038/ejcn.2013.238
    • Czuber-Dochan W, Norton C, Bassett P, Berliner S, Bredin F, Darvell M, Forbes A, Gay M, Nathan I, Ream E, Terry H (2014). Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale.. J Crohns Colitis, , - . doi:10.1016/j.crohns.2014.04.013

    2013

    • Wong SSH (2013). Nutritional supplement use in patients admitted to spinal cord injury centre. Journal of Spinal Cord Medicine, , - . doi:10.1179/2045772313Y.0000000105
    • Berghöfer P, Fragkos KC, Baxter JP, Forbes A, Joly F, Heinze H, Loth S, Pertkiewicz M, Messing B, Jeppesen PB (2013). Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale. Clinical Nutrition, , - . doi:10.1016/j.clnu.2012.12.001
    • Kuku S, Fragkos C, McCormack M, Forbes A (2013). Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers. British Journal of Cancer, , - . doi:10.1038/bjc.2013.491
    • Wong S, Graham A, Hirani S, Grimble G, Forbes A (2013). Validation of the Screening Tool for the Assessment of Malnutrition in Paediatrics (STAMP) in patients with spinal cord injuries (SCIs). Spinal Cord, 51(5), 424 - 429. doi:10.1038/sc.2012.166
    • Nathan I, Fragos KC, Forbes A (2013). THE MULTIDIMENSIONAL NATURE OF IBD FATIGUE: A SYSTEMATIC REVIEW AND META-ANALYSIS. doi:10.1136/gutjnl-2013-304907.362
    • Papadia C, Fonaroli F, Lanzarotto F, Salemme M, Di Sabatino A, de'Angelis G, Villanacci V, Corazza GR, Forbes A (2013). IS PLASMA CITRULLINE CONCENTRATION A RELIABLE MARKER FOR DIAGNOSIS AND CLINICAL MANAGEMENT OF COELIAC DISEASE ?. doi:10.1136/gutjnl-2013-304907.277
    • Nathan I, Norton C, Czuber-Dochan W, Forbes A (2013). Exercise in individuals with inflammatory bowel disease.. Gastroenterol Nurs, 36(6), 437 - 442. doi:10.1097/SGA.0000000000000005
    • Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V (2013). Understanding Patients' Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework.. PLoS One, 8(12), e80633 - . doi:10.1371/journal.pone.0080633
    • Papada E, Gioxari A, Kaliora , Papalois A, Forbes A (2013). ELEMENTAL DIETS WITH DIFFERENT FAT COMPOSITION IN EXPERIMENTAL COLITIS. ANNALS OF NUTRITION AND METABOLISM, 63, 339 - 339.
    • Papadia C, Louwagie J, Del Rio P, Grooteclaes M, Coruzzi A, Montana C, Novelli M, Bordi C, De' Angelis GL, Bassett P, Bigley J, Warren B, Atkin W, Forbes A (2013). FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia.. Inflamm Bowel Dis, , - . doi:10.1097/01.MIB.0000435443.07237.ed
    • Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghoefer P (2013). Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide - Analyses from a randomised, placebo-controlled study. CLINICAL NUTRITION, 32(5), 713 - 721. doi:10.1016/j.clnu.2013.03.016
    • Papada E, Kaliora AC, Gioxari A, Papalois A, Forbes A (2013). Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis.. Br J Nutr, , 1 - 8. doi:10.1017/S0007114513003632
    • Makanyanga JC, Pendsé D, Dikaios N, Bloom S, McCartney S, Helbren E, Atkins E, Cuthbertson T, Punwani S, Forbes A, Halligan S, Taylor SA (2013). Evaluation of Crohn's disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin.. Eur Radiol, , - . doi:10.1007/s00330-013-3010-z
    • Wong S, Barnes T, Coggrave M, Forbes A, Pounds-Cornish E, Appleton S, Belci M (2013). Morbid obesity after spinal cord injury: an ailment not to be treated?. Eur J Clin Nutr, , - . doi:10.1038/ejcn.2013.129
    • Papadia C, Maffei E, Del Rio P, Taylor S, Caini S, Montana C, Coruzzi A, Franzè A, Cademartiri F, Forbes A (2013). Sensitivity and Specificity of Magnetic Resonance Enterography in the Clinical Management of Fistulizing Crohn's Disease.. Inflamm Bowel Dis, , - . doi:10.1097/MIB.0b013e31828f19a5
    • Nathan I, Fragkos KC, Forbes A (2013). Correlates of IBD fatigue: a meta-analysis and systematic review. Journal of Crohn's and Colitis, 7(Supplement 1), S227 - . doi:10.1016/S1873-9946(13)60563-2
    • Mead S, Gandhi S, Beck J, Caine D, Gallujipali D, Carswell C, Hyare H, Joiner S, Ayling H, Lashley T, Linehan JM, Al-Doujaily H, Sharps B, Revesz T, Sandberg M, Reilly M, Koltzenburg M, Forbes A, Rudge P, Brandner S, Warren JD, Wadsworth JDF, Wood NW, Holton JL, Collinge J (2013). A Novel Prion Disease Presenting with Diarrhea and Autonomic Neuropathy. New England Journal of Medicine, , - .

    2012

    • Menys A, Helbren E, Makanyanga J, Halligan S, Atkinson D, Taylor S (2012). Small bowel strictures in Crohn’s Disease: A quantitative investigation of intestinal motility using MR Enterography.
    • Thoua NM, Abdel-Halim M, Forbes A, Denton CP, Emmanuel AV (2012). Fecal incontinence in systemic sclerosis is secondary to neuropathy.. Am J Gastroenterol, 107(4), 597 - 603. doi:10.1038/ajg.2011.399
    • Wong S, Graham A, Harini SP, Grimble G, Forbes A (2012). Profile and prevalence of malnutrition in children with spinal cord injuries-assessment of the Screening Tool for Assessment of Malnutrition in Paediatrics (STAMP).. Spinal Cord, 50(1), 67 - 71. doi:10.1038/sc.2011.139
    • Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, Bond G, Gupte G, Pertkiewicz M, Steiger E, Forbes A, Van Gossum A, Pinna AD, ESPEN (2012). Outcome on home parenteral nutrition for benign intestinal failure: A review of the literature and benchmarking with the European prospective survey of ESPEN. CLINICAL NUTRITION, 31(6), 831 - 845. doi:10.1016/j.clnu.2012.05.004
    • Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'Keefe SJD, Forbes A, Heinze H, Joelsson B (2012). Teduglutide Reduces Need for Parenteral Support Among Patients With Short Bowel Syndrome With Intestinal Failure. GASTROENTEROLOGY, 143(6), 1473 - +. doi:10.1053/j.gastro.2012.09.007
    • Wong SSH, Derry F, Jamous A, Harini S, Grimble G, Forbes A (2012). IS NUTRITIONAL RISK ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES SUCH AS LENGTH OF STAY AND MORTALITY IN SPINAL CORD INJURED PATIENTS ADMITTED TO A SPINAL CENTRE?. GUT, 61, A89 - A89. doi:10.1136/gutjnl-2012-302514b.39
    • Wong SSH, Spillman L, Doraikannu J, Graham A, Green D, Grimble G, Forbes A (2012). A RE-AUDIT TO EVALUATE THE USE OF THE SPINAL NUTRITION SCREENING TOOL IN THE NATIONAL SPINAL INJURIES CENTRE (NSIC) AT STOKE MANDEVILLE HOSPITAL. GUT, 61, A89 - A89. doi:10.1136/gutjnl-2012-302514b.38
    • Wong SSH, Graham A, Jamous A, Spillman L, Grimble G, Forbes A (2012). DIETARY INTERVENTION FOR INDIVIDUALS WITH SPINAL CORD INJURIES-A 2 YEAR REPORT ON THE SPINAL CLINIC FOR OBESE OUT-PATIENT PROJECT (SCOOP). GUT, 61, A96 - A96. doi:10.1136/gutjnl-2012-302514b.57
    • Benjamin JL, Hedin CRH, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, Pessoa-Lopes P, Mathew CG, Sanderson J, Hart AL, Kamm MA, Knight SC, Forbes A, Stagg AJ, Lindsay JO, Whelan K (2012). Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. INFLAMMATORY BOWEL DISEASES, 18(6), 1092 - 1100. doi:10.1002/ibd.21864
    • Hamad A, Fragkos KC, Forbes A (2012). Probiotics for Prevention of Radiation Induced Bowel Disease: New Findings and Updated Meta-Analysis. Annals of Oncology, 23(Suppl 4), iv66 - iv66. doi:10.1093/annonc/mds153
    • Al-Sulttan FM, Fragkos KC, Bogdanos DP, Forbes A (2012). A Systematic Review and Meta-Analysis of Pancreatic Autoantibody's (Pab) Diagnostic Accuracy vs Standard Diagnosis in Patients With Inflammatory Bowel Disease. Gastroenterology, 142(5(Suppl 1)), S778 - S779. doi:10.1016/S0016-5085(12)63018-2
    • Wong S, Graham A, Green D, Hirani SP, Grimble G, Forbes A (2012). Meal provision in a UK National Spinal Injury Centre: a qualitative audit of service users and stakeholders.. Spinal Cord, 50(10), 772 - 777. doi:10.1038/sc.2012.43
    • Wong S, Derry F, Graham A, Grimble G, Forbes A (2012). An audit to assess awareness and knowledge of nutrition in a UK spinal cord injuries centre.. Spinal Cord, 50(6), 446 - 451. doi:10.1038/sc.2011.180
    • Wong S, Derry F, Jamous A, Hirani SP, Grimble G, Forbes A (2012). Validation of the spinal nutrition screening tool (SNST) in patients with spinal cord injuries (SCI): result from a multicentre study.. Eur J Clin Nutr, 66(3), 382 - 387. doi:10.1038/ejcn.2011.209
    • Balogun N, Forbes A, Widschwendter M, Lanceley A (2012). Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction.. Int J Gynecol Cancer, 22(6), 1089 - 1095. doi:10.1097/IGC.0b013e318256e4d3

    2011

    • Fragkos K, Forbes A (2011). Was citrulline first a laxative substance? The truth about modern citrulline and its isolation. Nihon ishigaku zasshi / Journal of Japanese history of medicine, 57(3), 275 - 292.
    • Forbes A, Goldesgeyme E, Paulon E (2011). Nutrition in Inflammatory Bowel Disease. JPEN-PARENTER ENTER, 35(5), 571 - 580. doi:10.1177/0148607111413599
    • Ahmadi R, Mordan N, Forbes A, Day RM (2011). Enhanced attachment, growth and migration of smooth muscle cells on microcarriers produced using thermally induced phase separation.. Acta Biomater, 7(4), 1542 - 1549. doi:10.1016/j.actbio.2010.12.022
    • Fragkos K, Forbes A (2011). Digestion and absorption of nutrients. In Sobotka L, Allison S, Forbes A, Ljungqvist O, Pertkiewicz M, Meier R, Soeters PB (Ed.), Basics in Clinical Nutrition (pp. 83 - 96). : Galen.
    • Grimble GK, Wong SS, Graham A, Forbes A (2011). Spinal clinic for obese out-patient project (SCOOP) - a 1 year report. Food and Nutrition Sciences, 2(8), 901 - 907. doi:10.4236/fns.2011.28123
    • Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, Gabe S, Hebuterne X, Gambarara M, Gottrand F, Cuerda C, Thul P, Messing B, Goulet O, Staun M, Van Gossum A, European Soc Clinical Nutr & Metab (2011). Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. GUT, 60(1), 17 - 25. doi:10.1136/gut.2010.223255
    • Fragkos KC, Al-Sulttan FM, Mookerjee RP, Winstanley A, Forbes A (2011). Review of the literature and description of a case of Sclerosing Encapsulating Peritonitis requiring home parenteral nutrition. Zeitschrift für Gastroenterologie, 49(12), 1543 - 1548. doi:10.1055/s-0031-1281847
    • Ng SC, Benjamin JL, McCarthy NE, Hedin CRH, Koutsoumpas A, Plamondon S, Price CL, Hart AL, Kamm MA, Forbes A, Knight SC, Lindsay JO, Whelan K, Stagg AJ (2011). Relationship Between Human Intestinal Dendritic Cells, Gut Microbiota, and Disease Activity in Crohn's Disease. INFLAMM BOWEL DIS, 17(10), 2027 - 2037. doi:10.1002/ibd.21590
    • Papadia C, Louwagie J, Del Rio P, Grooteclaes M, Coruzzi A, Montana C, Franze A, Novelli M, Bordi C, Bryan W, Atkin W, Forbes A (2011). MODULATE COLITIS SURVEILLANCE: FOXE1 AND SYNE1 HYPERMETHYLATION IN COLITIS ASSOCIATED COLORECTAL CANCER (CAC). DIGEST LIVER DIS, 43, S132 - S133.
    • Quilliot D, Forbes A, Dubois F, Gueant JL, Ziegler O (2011). Carotenoid deficiency in chronic pancreatitis: the effect of an increase in tomato consumption. EUR J CLIN NUTR, 65(2), 262 - 268. doi:10.1038/ejcn.2010.232
    • Wong SSH, Derry F, Grimble G, Forbes A (2011). How do spinal cord injury centres manage malnutrition? A cross-sectional survey of 12 regional centres in the United Kingdom and Ireland. Spinal Cord, 50(2), 132 - 135. doi:10.1038/sc.2011.118

    2010

    • Keshaw H, Thapar N, Burns AJ, Knowles J, Forbes A, Day RM (2010). Microporous collagen spheres produced via thermally induced phase separation for tissue regeneration. Acta Biomaterialia, 6(3), 1158 - 1166. doi:10.1016/j.actbio.2009.08.044
    • Foong KS, Patel R, Forbes A, Day RM (2010). Anti-TNF-alpha-Loaded Microspheres as a Prospective Novel Treatment for Crohn's Disease Fistulae. Tissue Engineering, 16(5), 855 - 864. doi:10.1089/ten.tec.2009.0599
    • Keshaw H, Foong KS, Forbes A, Day RM (2010). Perianal Fistulae in Crohn’s Disease: Current and Future Approaches to Treatment. Inflammatory Bowel Diseases, 16(5), 870 - 880.
    • Foong KS, Patel R, Forbes A, Day RM (2010). Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn's disease fistulae.. Tissue Eng Part C Methods, 16(5), 855 - 864. doi:10.1089/ten.TEC.2009.0599
    • Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S, Vukcevic D, Barnes C, Conrad DF, Giannoulatou E, Holmes C, Marchini JL, Stirrups K, Tobin MD, Wain LV, Yau C, Aerts J, Ahmad T, Andrews TD, Arbury H, Attwood A, Auton A, Ball SG, Balmforth AJ, Barrett JC, Barroso I, Barton A, Bennett AJ, Bhaskar S, Blaszczyk K, Bowes J, Brand OJ, Braund PS, Bredin F, Breen G, Brown MJ, Bruce IN, Bull J, Burren OS, Burton J, Byrnes J, Caesar S, Clee CM, Coffey AJ, Connell JMC, Cooper JD, Dominiczak AF, Downes K, Drummond HE, Dudakia D, Dunham A, Ebbs B, Eccles D, Edkins S, Edwards C, Elliot A, Emery P, Evans DM, Evans G, Eyre S, Farmer A, Ferrier IN, Feuk L, Fitzgerald T, Flynn E, Forbes A, Forty L, Franklyn JA, Freathy RM, Gibbs P, Gilbert P, Gokumen O, Gordon-Smith K, Gray E, Green E, Groves CJ, Grozeva D, Gwilliam R, Hall A, Hammond N, Hardy M, Harrison P, Hassanali N, Hebaishi H, Hines S, Hinks A, Hitman GA, Hocking L, Howard E, Howard P, Howson JMM, Hughes D, Hunt S, Isaacs JD, Jain M, Jewell DP, Johnson T, Jolley JD, Jones IR, Jones LA, Kirov G, Langford CF, Lango-Allen H, Lathrop GM, Lee J, Lee KL, Lees C, Lewis K, Lindgren CM, Maisuria-Armer M, Maller J, Mansfield J, Martin P, Massey DCO, McArdle WL, McGuffin P, McLay KE, Mentzer A, Mimmack ML, Morgan AE, Morris AP, Mowat C, Myers S, Newman W, Nimmo ER, O'Donovan MC, Onipinla A, Onyiah I, Ovington NR, Owen MJ, Palin K, Parnell K, Pernet D, Perry JRB, Phillips A, Pinto D, Prescott NJ, Prokopenko I, Quail MA, Rafelt S, Rayner NW, Redon R, Reid DM, Renwick A, Ring SM, Robertson N, Russell E, St Clair D, Sambrook JG, Sanderson JD, Schuilenburg H, Scott CE, Scott R, Seal S, Shaw-Hawkins S, Shields BM, Simmonds MJ, Smyth DJ, Somaskantharajah E, Spanova K, Steer S, Stephens J, Stevens HE, Stone MA, Su Z, Symmons DPM, Thompson JR, Thomson W, Travers ME, Turnbull C, Valsesia A, Walker M, Walker NM, Wallace C, Warren-Perry M, Watkins NA, Webster J, Weedon MN, Wilson AG, Woodburn M, Wordsworth BP, Young AH, Zeggini E, Carter NP, Frayling TM, Lee C, McVean G, Munroe PB, Palotie A, Sawcer SJ, Scherer SW, Strachan DP, Tyler-Smith C, Brown MA, Burton PR, Caulfield MJ, Compston A, Farrall M, Gough SCL, Hall AS, Hattersley AT, Hill AVS, Mathew CG, Pembrey M, Satsangi J, Stratton MR, Worthington J, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Parkes M, Rahman N, Todd JA, Samani NJ, Donnelly P, Wellcome Trust Case Control (2010). Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. NATURE, 464(7289), 713 - U86. doi:10.1038/nature08979
    • Smith PJ, Marks DJ, Forbes A (2010). Parenteral nutrition.. Br J Hosp Med (Lond), 71(12), M185 - M189.
    • Benjamin JL, Hedin CRH, Koutsoumpas A, Ng SC, Hart AL, Kamm MA, Sanderson JD, Knight SC, Forbes A, Stagg AJ, Whelan K, Lindsay JO (2010). NO CLINICAL BENEFIT OF PREBIOTICS IN THE TREATMENT OF ACTIVE CROHN'S DISEASE: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL. doi:10.1136/gut.2009.208934c
    • Thoua NM, Bunce C, Brough G, Forbes A, Emmanuel AV, Denton CP (2010). Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre.. Rheumatology (Oxford), 49(9), 1770 - 1775. doi:10.1093/rheumatology/keq147

    2009

    • Keshaw H, Georgiou G, Blaker JJ, Forbes A, Knowles JC, Day RM (2009). Assessment of Polymer/Bioactive Glass-Composite Microporous Spheres for Tissue Regeneration Applications. Tissue Engineering: Part A, 15(7), 1451 - 1461. doi:10.1089/ten.tea.2008.0203
    • Staun M, Pironi L, Bozzetti F, Baxter J, Forbes A, Joly F, Jeppesen P, Moreno J, Hebuterne X, Pertkiewicz M, Muhlebach S, Shenkin A, Van Gossum A (2009). ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients. CLIN NUTR, 28(4), 467 - 479. doi:10.1016/j.clnu.2009.04.001
    • Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C (2009). ESPEN Guidelines on Parenteral Nutrition: Intensive care. CLIN NUTR, 28(4), 387 - 400. doi:10.1016/j.clnu.2009.04.024
    • Taylor SA, Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Forbes A, Cohen R, Windsor A, Obichere A, Hansmann A, Rajan J, Novelli M, Halligan S (2009). Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.. Radiology, 251(2), 369 - 379. doi:10.1148/radiol.2512081292
    • Forbes A (2009). Iron and parenteral nutrition.. Gastroenterology, 137(5 Suppl), S47 - S54. doi:10.1053/j.gastro.2009.08.013
    • Forbes A, Marie I (2009). Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.. Rheumatology (Oxford), 48 Suppl 3, iii36 - iii39. doi:10.1093/rheumatology/ken485
    • Bozzetti F, Forbes A (2009). The ESPEN clinical practice guidelines on Parenteral Nutrition: Present status and perspectives for future research. CLIN NUTR, 28(4), 359 - 364. doi:10.1016/j.clnu.2009.05.010

    2008

    • Blaker JJ, Pratten J, Ready D, Knowles JC, Forbes A, Day RM (2008). Assessment of antimicrobial microspheres as a prospective novel treatment targeted towards the repair of perianal fistulae. Aliment.Pharmacol.Ther., 28(5), 614 - 622.
    • Johnson MW, Gonzalez-Cinca N, Ellis JR, Forbes A, Ciclitira PJ, Nicholls R (2008). The role of macrophages and lymphocytes in acute pouchitis.
    • Mawdsley JE, Hollington P, Bassett P, Windsor AJ, Forbes A, Gabe SM (2008). An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. ALIMENT PHARM THER, 28(9), 1111 - 1121. doi:10.1111/j.1365-2036.2008.03819.x
    • Koak Y, Gertner D, Forbes A, Ribeiro BF (2008). Idiopathic sclerosing peritonitis. EUR J GASTROEN HEPAT, 20(2), 148 - 150.
    • Johnson MW, Das P, Rippingale C, Forbes A, Ciclitira PJ, Nicholls R (2008). The outcome of pouch surgery in older patients.
    • Haycock A, Hoare J, Patel J, Ralphs S, Forbes A (2008). Oral ciclosporin for chronically active steroid-dependent ulcerative colitis.
    • Abdullahi M, Jimenez IO, Pavlidis C, Siakouli P, Forbes A (2008). Comparison of a simple global rating with established scoring systems for inflammatory bowel disease.
    • Ng SC, Koutsoumpas A, Hedin CR, McCarthy NE, Plamondon S, Kamm MA, Knight SC, Forbes A, Lindsay JO, Whelan K, Stagg AJ (2008). Production of il-10 by colonic dendritic cells is associated with higher concentrations of faecal microbiota in patients with active crohn's disease.
    • Onnie CM, Fisher SA, Prescott NJ, Mirza MM, Green P, Sanderson J, Forbes A, Lewis CM, Mathew CG (2008). Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease. EUR J GASTROEN HEPAT, 20(1), 37 - 45.
    • Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, Prescott NJ, Nimmo ER, Massey D, Berzuini C, Johnson C, Barrett JC, Cummings FR, Drummond H, Lees CW, Onnie CM, Hanson CE, Blaszczyk K, Inouye M, Ewels P, Ravindrarajah R, Keniry A, Hunt S, Carter M, Watkins N, Ouwehand W, Lewis CM, Cardon L, Lobo A, Forbes A, Sanderson J, Jewell DP, Mansfield JC, Deloukas P, Mathew CG, Parkes M, Satsangi J, Wellcome Trust Case Control Consor (2008). Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. NAT GENET, 40(6), 710 - 712. doi:10.1038/ng.145
    • Culkin A, Gabe SM, Bjarnason I, Grimble G, Madden AM, Forbes A (2008). A double-blind, randomized, controlled crossover trial of glutamine supplementation in home parenteral nutrition. EUR J CLIN NUTR, 62(5), 575 - 583. doi:10.1038/sj.ejcn.1602754
    • Koutsoumpas A, Hedin CRH, Ng SC, Kamm MA, Sanderson JD, Knight SC, Stagg AJ, Forbes A, Lindsay JO, Whelan K (2008). Smokers with active crohn's disease have differences in the concentration and proportion of key bacterial groups of the faecal microbiota.
    • Hedin CRH, Koutsoumpas A, Forbes A, Sanderson J, Stagg AJ, Knight SC, Whelan K, Lindsay JO (2008). Factors that limit recruitment to clinical trials in crohn's disease.

    2007

    • Datta VK, Dann S, Engledow A, Privitera A, Cohen R, Forbes A, Windsor A (2007). Can enterocutaneous fistula be effectively managed in a regional unit?.
    • Banks C, Forbes A (2007). Topical treatment of ulcerative colitis. Some reflections.. Dig Liver Dis, 39(4), 338 - 341. doi:10.1016/j.dld.2006.11.001
    • Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans D, Leung HT, Marchini JL, Morris AP, Spencer CCA, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskvina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop DT, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Mathew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop GM, Connell J, Dominiczak A, Marcano CAB, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue MZ, Caulfield M, Farrall M, Barton A, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hider SL, Hinks AM, John SL, Potter C, Silman AJ, Symmons DPM, Thomson W, Worthington J, Dunger DB, Widmer B, Frayling TM, Freathy RM, Lango H, Perry JRB, Shields BM, Weedon MN, Hattersley AT, Hitman GA, Walker M, Elliott KS, Groves CJ, Lindgren CM, Rayner NW, Timpson NJ, Zeggini E, Newport M, Sirugo G, Lyons E, Vannberg F, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Hill AVS, Bradbury LA, Farrar C, Pointon JJ, Wordsmith P, Gough SCL, Seal S, Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Bumpstead SJ, Chaney A, Downes K, Ghori MJR, Gwilliam R, Inouye M, Keniry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whittaker P, Withers D, Easton D, Pereira-Gale J, Hallgrimsdottir IB, Howie BN, Su Z, Teo YY, Vukcevic D, Bentley D, Caulfield M, Mathew CG, Worthington J, Wellcome Trust Case Control Consortium , Biol RA Genet & Genom Study Syndicate , Breast Canc Susceptib Collaborat (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. NATURE, 447(7145), 661 - 678. doi:10.1038/nature05911
    • Forbes A (2007). Global guidelines for nutrition support. LANCET, 370(9603), 1906 - 1906.
    • Lewis CM, Whitwell SCL, Forbes A, Sanderson J, Mathew CG, Marteau TM (2007). Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J MED GENET, 44(11), 689 - 694. doi:10.1136/jmg.2007.051672
    • Lewis CM, Whitwell SCL, Forbes A, Sanderson J, Mathew CG, Marteau TM (2007). Risk estimation for common complex genetic disorders: using genetic, environmental and family history information in Crohn's disease.
    • Bell AJG, Price AB, Forbes A, Ciclitira PJ, Nicholls RJ (2007). Pre-pouch ileitis. ALIMENT PHARM THER, 26(6), 963 - 964. doi:10.1111/j.1365-2036.2007.03436.x
    • Mansfield JC, Parkes M, Hawthorne AB, Forbes A, Probert CSJ, Perowne RC, Cooper A, Zeldis JB, Manning DC, Hawkey CJ (2007). A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. ALIMENT PHARM THER, 26(3), 421 - 430. doi:10.1111/j.1365-2036.2007.03385.x
    • Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, Cardon L, Mathew CG, Wellcome Trust Case Control Consor (2007). Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. NAT GENET, 39(7), 830 - 832. doi:10.1038/ng2061
    • Steinhart AH, Forbes A, Mills EC, Rodgers-Gray BS, Travis SPL (2007). Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease. ALIMENT PHARM THER, 25(12), 1389 - 1399. doi:10.1111/j.1365-2036.2007.03324.x
    • Fisher SA, Mirza MM, Onnie CM, Soars D, Lews CM, Prescott NJ, Mathew CG, Sanderson J, Forbes A, Todhunter C, Donaldson P, Mansfield J (2007). Combined evidence from three large British association studies rejects TUCAN/CARD8 as an IBD susceptibility gene. GASTROENTEROLOGY, 132(5), 2078 - 2080. doi:10.1053/j.gastro.2007.03.086
    • Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ, Sanderson J, Bredin F, Berzuini C, Forbes A, Lewis CM, Cardon L, Deloukas P, Jewell D, Mathew CG, Parkes M, Satsangi J (2007). IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. GASTROENTEROLOGY, 132(5), 1657 - 1664. doi:10.1053/j.gastro.2007.02.051
    • Prescott NJ, Fisher SA, Franke A, Onnie CM, Hampe J, Todhunter CE, Soars D, Sanderson J, Forbes A, Mansfield J, Lewis CM, Schreiber S, Mathew CG (2007). A non-synonymous SNP in an autophagy-related gene is associated with Crohn's disease.
    • Pearce AV, Fisher SA, Prescott NJ, Onnie CM, Pattni R, Green P, Forbes A, Mansfield J, Sanderson J, Schreiber S, Lewis CM, Mathew CG (2007). Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population. INT J COLORECTAL DIS, 22(4), 419 - 424. doi:10.1007/s00384-006-0151-4
    • Wallis K, Walters JRF, Forbes A (2007). Review article: glucagon-like peptide 2 - current applications and future directions. ALIMENT PHARM THER, 25(4), 365 - 372. doi:10.1111/j.1365-2036.2006.03193.x
    • Windsor A, Forbes A (2007). Is the multidisciplinary team essential for the future management of patients with inflammatory bowel disease?. Colorectal Dis, 9(6), 478 - 479. doi:10.1111/j.1463-1318.2007.01293.x
    • Forbes A (2007). Parenteral nutrition.. Curr Opin Gastroenterol, 23(2), 183 - 186. doi:10.1097/MOG.0b013e328012134a

    2006

    • Keshaw H, Sibbons PD, Forbes A, Day RM (2006). Development of a collagen-ceramic composite for fistula repair. Gut, 55, A86 - A87.
    • Harbord MW, Marks DJ, Forbes A, Bloom SL, Day RM, Segal AW (2006). Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Aliment.Pharmacol.Ther., 24(4), 651 - 660.
    • Forbes A (2006). Parenteral nutrition.. Curr Opin Gastroenterol, 22(2), 160 - 164. doi:10.1097/01.mog.0000203869.22706.84
    • Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A (2006). Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.. Gastroenterology, 130(4), 1030 - 1038. doi:10.1053/j.gastro.2005.12.035
    • Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchel R, Hawkey CJ, European Crohns Colitis Org ECCO (2006). European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. GUT, 55, - . doi:10.1136/gut.2005.081950c
    • van Heel DA, Hunt KA, King K, Ghosh S, Gabe SM, Mathew CG, Forbes A, Playford RJ (2006). Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease. INFLAMM BOWEL DIS, 12(7), 598 - 605.
    • Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm M, Knight SC, Forbes A (2006). The clinical, microbiological and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease.. Gut, 55, 348 - 355.
    • Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, Sanderson J, Mansfield J, Annese V, Forbes A, Lewis CM, Schreiber S, Rioux JD, Mathew CG (2006). Direct or indirect association in a complex disease: The role of SLC22A4 and SLC22A5 functional variants in Crohn disease. HUM MUTAT, 27(8), 778 - 785. doi:10.1002/humu.20358
    • Principi M, Day R, Marangi S, Burattini O, De F, V I, M P, A P, C F, A D, Leo A F, A I, E (2006). Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn's disease. Immunopharmacol.Immunotoxicol., 28(2), 185 - 195.
    • Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, Mathew CG (2006). Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: A case-control and meta-analysis study. INFLAMM BOWEL DIS, 12(4), 263 - 271.
    • Onnie C, Fisher SA, King K, Mirza M, Roberts R, Forbes A, Sanderson J, Lewis CM, Mathew CG (2006). Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31. GENES IMMUN, 7(5), 359 - 365. doi:10.1038/sj.gene.6364307
    • Lloyd DAJ, Vega R, Bassett P, Forbes A, Gabe SM (2006). Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. ALIMENT PHARM THER, 24(8), 1231 - 1240. doi:10.1111/j.1365-2036.2006.03106.x
    • Polymeros D, Bogdanos D, Day R, Arioli D, Vergani D, Forbes A (2006). Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology, 131(1), 85 - 96. doi:10.1053/j.gastro.2006.04.021
    • Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A (2006). Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.. Gastroenterology, 126, 451 - 459.
    • Reid EP, Forbes A, Sanderson J, Mathew CG, Lewis C, Marteau TM (2006). Recruiting first-degree relatives for prevention research: a comparison of clinician and proband-led methods of contact in Crohn's disease. EUR J HUM GENET, 14(12), 1263 - 1268. doi:10.1038/sj.ejhg.5201699
    • Travis SPL, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ, European Crohns Colitis Org ECCO (2006). European evidence based consensus on the diagnosis and management of Crohn's disease: current management. GUT, 55, - . doi:10.1136/gut.2005.081950b

    2005

    • Day RM, Maquet V, Boccaccini AR, Jerome R, Forbes A (2005). In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co-glycolide) scaffolds containing bioactive glass. J.Biomed.Mater.Res.A, 75(4), 778 - 787. doi:10.1002/jbm.a.30433
    • Van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg A, Ahmad T, McGovern DPB, Onnie C, Negoro K, Goldthorpe S, Foxwell BMJ, Mathew CG, Forbes A, Jewell DP, Playford RJ (2005). Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.. The Lancet, 365(9473), 1794 - 1796. doi:10.1016/S0140-6736(05)66582-8
    • Keshaw H, Forbes A, Day RM (2005). Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials, 26(19), 4171 - 4179. doi:10.1016/j.biomaterials.2004.10.021
    • Marks D, Oukrif D, Novelli M, Forbes A, Segal AW, Harbord M (2005). Impaired acute inflammation in the terminal ileum of Crohn's patients.
    • Barratt HS, Kalantzis C, Polymeros D, Forbes A (2005). Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status.. Alimentary Pharmacology and Therapeutics, 21, 141 - 147.

    2004

    • Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A (2004). Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.. Gastroenterology, 126(2), 451 - 459. doi:10.1053/j.gastro.2003.11.010
    • Emmanuel AV, Stern J, Traesure J, Forbes A, Kamm MA (2004). Anorexia nervosa in gastrointestinal practice. European Journal of Gastroenterology and Hepatology, 16(11), 1135 - 1142.
    • Day RM, Boccaccini AR, Maquet V, Shurey S, Forbes A, Gabe SM, Jerome R (2004). In vivo characterisation of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J.Mater.Sci.Mater.Med., 15(6), 729 - 734.
    • Day RM, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, Gabe SM (2004). Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials, 25(27), 5857 - 5866. doi:10.1016/j.biomaterials.2004.01.043
    • Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A (2004). Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.. Gut, 53, 1813 - 1816.

    2003

    • Probert CSJ, Hearing SD, Schreiber S, Kühbacher T, Ghosh S, Arnott IDR, Forbes A (2003). Infliximab in steroid-resistant ulcerative colitis – a randomised controlled trial.. Gut, 52, 998 - 1002.
    • Day RM, Mitchell TJ, Knight SC, Forbes A (2003). Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine, 21(5), 224 - 233.

    2002

    • Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG (2002). The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.. Gastroenterology, 122, 867 - 874.
    • Harbord M, Day R, Hankin A, Bloom S, Forbes A, Segal AW (2002). Neutrophil respiratory burst and tissue penetration are normal in CD during G-CSF administration. GUT, 50, A67 - A67.
    • Day R, Harbord M, Segal A, Forbes A (2002). Differences in micro-vascular blood flow at sites of skin blistering may account for reduced leukocyte trafficking in Crohn's disease. GUT, 50, A77 - A77.

    2001

    • Hampe J, Cuthbert A, Croucher PJP, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJS, Bridger S, Van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG (2001). Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.. The Lancet, 357, 1925 - 1928.
    • Day RM, Harbord M, Forbes A, Segal AW (2001). Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. Journal of Immunological Methods, 257(1-2), 213 - 220. doi:10.1016/S0022-1759(01)00467-7
    • Harbord M, Day R, Bloom S, Knight S, Forbes A, Segal AW (2001). Neutrophil deficiency during acute inflammation in inflammatory bowel disease. GUT, 48, A20 - A20.
    • Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366 - 372.

    1999

    • Day R, Ilyas M, Daszak P, Talbot I, Forbes A (1999). Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig.Dis.Sci., 44(12), 2508 - 2515.
    • Day R, Forbes A (1999). Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet, 354(9172), 62 - 65.
    • Day RM, Hao X, Ilyas M, Daszak P, Talbot IC, Forbes A (1999). Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch., 434(2), 121 - 125.

    1997

    • Ilyas M, Novelli M, Wilkinson K, Tomlinson IPM, Abbasi AM, Forbes A, Talbot IC (1997). Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Duke's B colorectal cancers. Journal of Clinical Pathology, 50(3), 218 - 222.

    1993

    • Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm ADB, Begent RHJ (1993). CD44 is associated with proliferation in normal and neoplastic human colorectal epitheial-cells. European Journal of Cancer, 29A(14), 1995 - 2002.

    • Wong SS, Jamous A, O'Driscoll J, Sekhar R, Weldon M, Yau CY, Hirani S, Grimble GK, Forbes A (). A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial. The British Journal of Nutrition: an international journal of nutritional science, , - . doi:10.1017/S0007114513002973
    • Taylor SA, Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Forbes A, Cohen R, Windsor A, Obichere A, Hansmann A, Rajan J, Novelli M, Halligan S (). Dynamic contrast enhanced MRI of mural Crohn’s disease: Correlation with histological angiogenesis and inflammation-a pilot study. Radiology, , - .
    • Hamad A, Forbes A, Fragkos KC (). A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clinical Nutrition, , - . doi:10.1016/j.clnu.2013.02.004
    • Hamad A, Fragkos K, Forbes A (). Probiotics for prevention of radiation induced bowel disease: New findings and updated meta-analysis. Neurogastroenterology & Motility, 24(Suppl S2), 185 - 186. doi:10.1111/j.1365-2982.2012.01997.x
    • Wong SSH, Derry F, Jamous A, Hirani SP, Grimble G, Forbes A (). The prevalence of malnutrition in spinal cord injuries patients: a UK multicentre study. British Journal of Nutrition, , - . doi:10.1017/S0007114511006234